Figure 4.
Flow cytometry (a) and mass cytometry (b–c) detection of CD3+ T cells in PBMCs using biotinlyated anti-human CD3 antibody as the primary antibody, followed by labeling with (a–b) 2 ppm Pdots-PC-Ho-SA, and (c) commercial available anti-biotin-Ho165 probe.